This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ citalopram hydrobromide,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Major Depressive Disorder (MDD): Citalopram hydrobromide is indicated for the treatment of major depressive disorder, also known as clinical depression. It works by increasing the levels of serotonin, a neurotransmitter in the brain associated with mood regulation. By enhancing serotonin transmission, citalopram helps alleviate symptoms of depression, including persistent sadness, loss of interest or pleasure in activities, changes in appetite or weight, sleep disturbances, fatigue, feelings of worthlessness or guilt, and difficulty concentrating.

  2. Generalized Anxiety Disorder (GAD): Citalopram hydrobromide may also be used off-label for the treatment of generalized anxiety disorder (GAD), a chronic condition characterized by excessive worry or anxiety about various aspects of life. It can help reduce symptoms such as excessive worry, restlessness, irritability, muscle tension, and difficulty concentrating.

  3. Panic Disorder: Citalopram hydrobromide is effective in the treatment of panic disorder, a type of anxiety disorder characterized by recurrent panic attacks accompanied by intense fear or discomfort. It helps reduce the frequency and severity of panic attacks, as well as associated symptoms such as palpitations, sweating, trembling, shortness of breath, chest pain, nausea, dizziness, and fear of losing control or dying.

  4. Obsessive-Compulsive Disorder (OCD): Citalopram hydrobromide may be used off-label in the treatment of obsessive-compulsive disorder (OCD), a chronic condition characterized by intrusive, unwanted thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) performed in response to these obsessions. It can help reduce the frequency and intensity of obsessive thoughts and compulsive behaviors, allowing individuals to better manage their symptoms and improve their quality of life.

  5. Post-Traumatic Stress Disorder (PTSD): Citalopram hydrobromide may be used off-label for the treatment of post-traumatic stress disorder (PTSD), a mental health condition that can develop after experiencing or witnessing a traumatic event. It can help alleviate symptoms such as intrusive memories or nightmares, avoidance of trauma-related triggers, negative changes in mood or cognition, and heightened arousal or reactivity.

  6. Social Anxiety Disorder (SAD): Citalopram hydrobromide may be used off-label in the treatment of social anxiety disorder (SAD), also known as social phobia, which involves intense fear or anxiety about social situations and interactions. It can help reduce symptoms such as fear of embarrassment or humiliation, avoidance of social situations, and physical symptoms of anxiety (e.g., blushing, sweating, trembling).

  7. Side Effects: Common side effects of citalopram hydrobromide may include nausea, dry mouth, drowsiness, insomnia, headache, dizziness, sweating, tremor, sexual dysfunction (e.g., decreased libido, difficulty achieving orgasm), gastrointestinal disturbances (e.g., diarrhea, constipation, abdominal pain), and weight changes. Most side effects are mild to moderate in severity and often improve with continued use or dose adjustment.

  8. Serotonin Syndrome: Citalopram hydrobromide may rarely cause serotonin syndrome, a potentially life-threatening condition characterized by excessive serotonin activity in the brain. Symptoms of serotonin syndrome may include agitation, hallucinations, confusion, fever, sweating, rapid heart rate, elevated blood pressure, muscle stiffness, tremor, and seizures. Serotonin syndrome requires immediate medical attention and may necessitate discontinuation of citalopram hydrobromide and supportive care measures.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of citalopram hydrobromide,(prescription) On Probiotics

Bacteria Impacted by citalopram hydrobromide,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

Impact of citalopram hydrobromide,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]